Prismasol 2 mmol/l Potassium haemodialysis/haemofiltration sol.

Država: Belgija

Jezik: engleski

Izvor: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Kupi sada

Aktivni sastojci:

Sodium Hydrogen Carbonate 2,94 mg/ml; Potassium Chloride 0,15 mg/ml; Magnesium Chloride Hexahydrate 0,1017 mg/ml; Sodium Chloride 6,13 mg/ml; Lactic Acid 0,27 mg/ml; Glucose Monohydrate - Eq. Glucose Anhydrous 1,1 g/l; Calcium Chloride Dihydrate 5,145 g/l

Dostupno od:

Baxter Holding B.V.

ATC koda:

B05ZB

INN (International ime):

Glucose Monohydrate; Lactic Acid; Magnesium Chloride Hexahydrate; Potassium Chloride; Sodium Chloride; Sodium Bicarbonate; Calcium Chloride Dihydrate

Farmaceutski oblik:

Solution for haemodialysis/haemofiltration

Sastav:

Glucose Monohydrate; Lactic Acid 0.27 mg/ml; Magnesium Chloride Hexahydrate 0.1017 mg/ml; Potassium Chloride 0.15 mg/ml; Sodium Chloride 6.13 mg/ml; Sodium Bicarbonate 2.94 mg/ml; Calcium Chloride Dihydrate

Administracija rute:

Haemodialysis

Područje terapije:

Hemofiltrates

Proizvod sažetak:

CTI code: 335492-01 - Pack size: 2 x 5000 ml - Commercialisation status: YES - FMD code: 03400938128628 - CNK code: 4197414 - Delivery mode: Medical prescription; CTI code: 253583-01 - Pack size: 2 x 5000 ml - Commercialisation status: NO - FMD code: 03400938128628 - CNK code: 4197414 - Delivery mode: Medical prescription

Status autorizacije:

Commercialised: No

Datum autorizacije:

2003-07-07

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku njemački 22-03-2024
Uputa o lijeku Uputa o lijeku francuski 22-03-2024
Svojstava lijeka Svojstava lijeka francuski 10-01-2024
Uputa o lijeku Uputa o lijeku nizozemski 22-03-2024
Svojstava lijeka Svojstava lijeka nizozemski 10-01-2024